Open Access
Int Arch Otorhinolaryngol 2013; 17(01): 014-019
DOI: 10.7162/S1809-97772013000100003
Original Article
Thieme Publicações Ltda Rio de Janeiro, Brazil

Nasopharyngeal angiofibroma: Our experience and literature review

Authors

  • Mariane Barreto Brandão Martins

    1   Resident Doctor in the Department of Otolaryngology of the Federal University of Sergipe.
  • Francis Vinicius Fontes de Lima

    1   Resident Doctor in the Department of Otolaryngology of the Federal University of Sergipe.
  • Carlos Alberto Mendonça

    2   Professor in the Department of Head and Neck Surgery.
  • Eduardo Passos Fiel de Jesus

    3   Professor in the Department of Otolaryngology.
  • Arlete Cristina Granizo Santos

    3   Professor in the Department of Otolaryngology.
  • Valéria Maria Prado Barreto

    4   Masters in Health Sciences, Universidade Fedreral de Sergipe. Professor in the Department of Otolaryngology.
  • Ronaldo Carvalho Santos Júnior

    5   Doctor of Medicine by USP. Service chief medical residency in Otorhinolaryngology, Universidade Federal de Sergipe.
Further Information

Publication History

21 August 2012

07 October 2012

Publication Date:
06 January 2014 (online)

Preview

Summary

Introduction: Juvenile nasopharyngeal angiofibroma is a rare, highly vascular, and histologically benign tumor, generally observed in male adolescents. It shows very aggressive behavior due to local invasiveness and is associated with various symptoms. Juvenile nasopharyngeal angiofibroma originates in the sphenopalatine forame, causing epistaxes and nasal obstruction.

Objective: To retrospectively describe our experience in the diagnosis and treatment of patients with juvenile nasopharyngeal angiofibroma.

Scientific drawing: Retrospective, descriptive study conducted after approval from the Ethics Committee of the Federal University of Sergipe (protocol 0114.0.107.000 -11).

Methods: We analyzed findings in 20 patients who underwent surgery between 2004 and 2011. Factors analyzed include patient age and gender, symptoms, stages, treatment, length of surgery, intraoperatory bleeding, postoperative need for nasal tampons, hospitalization time, complications, and tumor recurrence.

Results: Patients were aged 10–29 years. All patients were treated surgically, including 17 who underwent endoscopic surgery. The mean operation time was 120 min, and the mean bleeding volume was 300 mL. Seventeen patients required clamping of the external carotids and tumor embolization.

Conclusion: Endoscopic surgery alone or with other conventional techniques was safe for the treatment of angiofibromas of different stages.